A Development Stage CO is categorized under Biotechnology Products and Services in Tampa, FL .
A Development Stage CO was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Calvin Cao, Chief Executive Officer at the company’s single location by writing to 2203 North Lois Avenue, Tampa, Florida FL 33607 or by phoning (813) 600-4088. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | A Development Stage CO |
Contact Person: | Calvin Cao, Chief Executive Officer |
Address: | 2203 North Lois Avenue, Tampa, Florida 33607 |
Phone Number: | (813) 600-4088 |
Website Address: | czbiomed.com |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Biotechnology Products and Services |
SIC Code: | 8731 |
NAICS Code: | 5417114 |
Share This Business: |
A Development Stage CO was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Calvin Cao, Chief Executive Officer for inquiries that concern A Development Stage CO by calling the company number (813) 600-4088, as your correspondence is most welcome. Additionally, the physical location of the single location of A Development Stage CO can be found at the coordinates 27.961336,-82.513706 as well as the street address 2203 North Lois Avenue in Tampa, Florida 33607.
For its online presence, you may visit A Development Stage CO’s website at czbiomed.com and engage with its social media outlets through on Twitter and on Facebook.